Research Publications - October 2020

1.     Doss MK, May DG, Johson MW, Clifton JM, Hedrick SL, Prisinzano TE, Griffiths RR, Barrett FS. (2020). The acute effects of the atypical dissociative hallucinogen salvinorin A on functional connectivity in the human brain. Sci Rep, doi: 10.1038/s41598-020-73216-8.

2.     Flannery AH, Owen GD, Coz A, Thompson-Bastin ML, Patel K. (2020). Impact of hyperoncotic albumin on duration of vasopressor support in septic shock: A propensity score-matched analysis. Ann Pharmacother, doi: 10.1177/1060028020963645.

3.     Rossi L, Pierge F, Agostini M, Bigini N, Termopoli V, Cai Y, Zheng F, Zhan CG, Landry DW, Magnani M. (2020). Efficient cocaine degradation by cocaine esterase-loaded red blood cells. Front Physiol, doi: 10.3389/fphys.2020.573492.

4.     Malcom DR, Cain J, Frederick EK, Johnson C. (2020). An exploratory assessment of epistemic curiosity in students at three doctor of pharmacy programs. Am J Pharm Educ, doi: 10.5688/ajpe7970.

5.     Agbana P, Lee MJ, Rychhou P, Kim KB, Bae Y. (2020). Ternary polypeptide nanoparticles with improves encapsulation, sustained release, and enhanced in vitro efficacy of carfilzomib. Pharm Res, doi: 10.1007/s11095-020-02922-9.

6.     Al-Darraji A, Donahue RR, Tripathi H, Peng H, Levitan BM, Chelvarajan L, Haydar D, Gao E, Henson D, Gensel JC, Feola DJ, Venditto VJ, Abdel-Latif A. (2020). Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction. Sci Rep, doi: 10.1038/s41598-020-73593-0.

7.     Baburaj G, Damerla RR, Udupa KS, Parida P, Munisamy M, Kolesar J, Rao M. (2020). Liquid biopsy approaches for pleura effusion in lung cancer patients. Mol Biol Rep, doi: 10.1007/s11033-020-05869-7.

8.     Flannery AH, Hammond DA, Oyler DR, Li C, Wong A, Smith AP, Yeo QM, Chaney W, Pfaff CE, Plewa-Rusiecki AM, Juang P. (2020). Vancomycin dosing practices among critical care pharmacists: A survey of society of critical care medicine pharmacists. Infect Dis (Auckl), doi: 10.1177/1178633720952078.

9.     Barlow B, Barlow A, Webb A, Cain J. (2020). “Capturing your audience”: Analysis of Twitter engagements between tweets linked with an educational infographic or a peer-reviewed journal article. J Vis Commun Med, doi: 10.1080/17453054.2020.1809358.

10.   Cook AM, Shutter L. (2020). Response to Drs. Quintard, et al. Neurocrit care, doi: 10.1007/s12028-020-01064-5.

11.   Jackson NA, Gan T, Davenport DL, Oyler DR, Ebbitt LM, Evers BM, Bhakta AS. (2020). Preoperative opioid, sedative, and antidepressant use is associated with increased postoperative hospital costs in colorectal surgery. Surg Endosc, doi: 10.1007/s00464-020-08062-w.

12.   Hardin R, Roberts P, Hudspeth B, Tracy A, Baldwin L, Raque M, Kebodeaux CD. (2020). Development and implementation of an influenza point-of-care testing service in a chain community pharmacy setting. Pharmacy (Basel), doi: 10.3390/pharmacy8040182.

13.   Wu E, Villani J, Davis A, Fareed N, Harris DR, Huerta TR, LaRochelle MR, Miller CC, Oga EA. (2020). Community dashboards to support data-informed decision-making in the HEALing communities study. Drug Alcohol Depend, doi: 10.1016/j.drugalcdep.2020.108331.

14.   Adams CD, Altshuler J, Barlow BL, Dixit D, Droege CA, Effendi MK, Heavner MS, Johnston JP, Kiskaddon AL, Lemieux DG, Lemieux SM, Littlefield AJ, Owusu KA, Rouse GE, Thompson Bastin ML, Berger K. (2020). Analgesia and sedation strategies in mechanically ventilated adults with COVID-19. Pharmacotherapy, doi: 10.1002/phar.2471.

15.   Thamban Chandrika N, Dennis EK, Brubaker KR, Kwiatkowski S, Watt DS, Garneau-Tsodikova S. (2020). Broad-spectrum antifungal agents: Fluorinated aryl- and heteroaryl-substituted hydrazones. ChemMedChem, doi: 10.1002/cmdc.20200626.

16.   Mayer KP, Boustany H, Cassity EP, Soper MK, Kalema A, Hatton Kolpek J, Montgomery-Yates AA. (2020). ICU recovery clinic attendance, attrition, and patient outcomes: The impact of severity of illness, gender, and rurality. Crit Care Explor, doi: 10.1097/CCD.0000000000000206.

17.   Martinez LS, Rapkin BD, Yound A, Freisthler B, Glasgow L, Hunt T, Salsberry PJ, Oga EA, Bennet-Fallin A, Plouck TJ, Drinoni ML, Freeman PR, Surratt H, Gulley J, Hamilton GA, Bowman P, Roeber CA, El-Bassel N, Battaglia T. (2020). Community engagement to implement evidence-based practices in the HEALing communities studies. Drug Alcohol Depend, doi: 10.1016/j.drugalcdep.2020.108326.

18.   Tateno M, Stone BJ, Srodulski SJ, Reedy S, Gawriluk TR, Chambers TM, Woodward J, Chappell J, Kempinski CF. (2020). Synthetic biology-derived triterpenes as efficacious immunomodulating adjuvants. Sci Rep, doi: 10.1038/s41598-010-73868-6.

19.   Li Z, Li X, Hung YY, Wu Y, Liu R, Zhou L, Lin Y, Wu D, Zhang L, Liu H, Xu X, Yu K, Zhang Y, Cui J, Zhan CG, Wang X, Luo HB. (2020). Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Proc Natl Acad Sci USA, doi: 10.1073/pnas.2010470117.

20.   El-Bassel N, Jackson RD, Samet J, Walsh SL. (2020). Introduction to the special issue on the HEALing communities study. Drug Alcohol Depend, doi: 10.1016/j.drugalcdep.2020.108327.

21.   Winhusen T, Walley A, Fanucchi LC, Hunt T, Lyons M, Lofwall M, Brown JL, Freeman RF, Nunes E, Beers D, Saitz R, Stambaugh L, Oga EA, Herron N, Baker T, Cook CD, Roberts M, Alford DP, Starrels JL, Chandler RK. (2020). The opioid-overdose reduction continuum of care approach (ORCCA): Evidence-based practices in the HEALing communities study. Drug Alcohol Depend, doi: 10.1016/j.drugalcdep.2020.108325.

22.   Huskinson SL, Platt DM, Brasfield M, Follett ME, Prisinzano TE, Blough BE, Freeman KB. (2020). Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys. Psychopharmacology (Berl), doi: 10.1007/s00213-020-05519-7.

23.   Tateno M, Stone BJ, Srodulski S, Reedy S, Gawriluk TR, Chambers TM, Woodward J, Chappell J, Kempinski CF. (2020). Synthetic biology-derived triterpenes as efficacious immunomodulating adjuvants. Sci Rep, doi: 10.1038/s41598-020-7368.

24.   Beavers CJ, Wayne NB. (2020). Osocimag: A novel agent in preventing venous thromboembolism. J Cardiovasc Pharmacol, doi: 10.1097/FJC.0000000000000921.

25.   Rich SN, Cook RL, Yaghjyan L, Francois K, Puttkammer N, Robin E, Bae J, Joseph N, Pessoa-Brandao L, Delcher C. (2020). Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017. PLoS One, doi: 10.1371/journal.pone.0240817.

If you have not done so, please remember to apply for PMC ID if applicable to support continued funding. Link to apply for PMC ID: